- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07272447
Effect of Hand Message on Catheter Insertion
The Effect of Arm Message on the Success of Peripheral Intravenous Catheter Insertion in Breast Cancer Patients Undergoing Chemotherapy
Study Overview
Detailed Description
Introduction: Peripheral intravenous catheter (PIVK) placement becomes difficult in patients diagnosed with breast cancer who receive chemotherapy because vein visibility decreases.
Objective: The aim of this study is to determine the effect of arm massage applied to patients diagnosed with breast cancer receiving chemotherapy on the success of peripheral intravenous catheter placement.
Method: The study will conducted in a randomized controlled experimental type in an outpatient chemotherapy unit of a hospital.The sample of the study will consist of 60 patients who met the inclusion criteria (experimental group = 30, control group = 30). Patients in the experimental group will receive arm massage before peripheral intravenous catheter placement, while patients in the control group will receive no intervention. The time to successful catheter placement, patient anxiety, and satisfaction levels regarding the procedure will be recorded.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Yalova, Turkey (Türkiye), (543) 871-2771
- Yalova University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- diagnosed as breast cancer,
- having had the first course of chemotherapy,
- patients who has 1,2 and 3 vein degree
Exclusion Criteria:
- More than 2 unsuccessful attempts at PICK placement,
- The individual wants to leave the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: experimental group
hand massage
|
Classical hand massage that inclued effleurage, and petrisage.
|
|
No Intervention: control group
no intervention has applied
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
the success of peripheral intravenous catheter insertion
Time Frame: assessed up to 6 months
|
Time until successful catheter placement
|
assessed up to 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
patient satisfaction level scale
Time Frame: assessed up to 6 months
|
Patient satisfaction levels with peripheral intravenous catheter placement procedure
|
assessed up to 6 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 224/187
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Breast Cancer
-
Baylor Breast Care CenterRecruitingBreast Cancer | Breast Neoplasm | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | HER2-positive Breast Cancer | Breast Cancer Stage II | Breast Cancer Female | Breast Cancer Stage III | Estrogen Receptor-positive Breast Cancer | Hormone Receptor-positive Breast Cancer | Breast Cancer InvasiveUnited States
-
Innocrin PharmaceuticalCompletedBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Male Breast Cancer | ER+ Breast Cancer | Cancer of the BreastUnited States
-
Northwestern UniversityEisai Inc.UnknownMale Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative...United States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyActive, not recruitingStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedMale Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedInflammatory Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage IIIB Breast Cancer | Estrogen Receptor-negative Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-negative Breast Cancer | Progesterone Receptor-positive Breast CancerUnited States
-
University of Central FloridaFlorida Department of HealthRecruitingBreast Cancer | Breast Cancer Female | Breast Cancer Diagnosis | Breast Cancer Survivors | Breast Cancer Detection | Breast Cancer AwarenessUnited States
-
CelgeneCompletedBreast Cancer | Metastatic Breast Cancer | Stage IV Breast Cancer | Triple-negative Breast Cancer | Recurrent Breast Cancer | Breast Tumor | Cancer of the Breast | Triple-negative Metastatic Breast Cancer | Estrogen Receptor- Negative Breast Cancer | HER2- Negative Breast Cancer | Progesterone Receptor- Negative...United States, United Kingdom, Italy, Germany, Spain, Canada, Portugal, Australia, Austria, Greece, Brazil, France
-
University of WashingtonTerminatedBreast Cancer | Breast Cancer Stage I | Breast Cancer Stage II | Breast Cancer Stage III | Breast Cancer Stage IIB | Breast Cancer Stage IIA | Breast Cancer Stage IIIA | Breast Cancer Stage IIIB | Breast Cancer Stage IIIcUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedHER2-positive Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
Clinical Trials on Hand massage
-
Dokuz Eylul UniversityCompletedPain | Hemodynamic Instability | Massage | Endotracheal Aspiration | ReflexologyTurkey
-
Mayo ClinicCompleted
-
Cukurova UniversityEnrolling by invitationPain | Sleep | Self EfficacyTurkey
-
Mersin UniversityCompletedHemodialysis PatientsTurkey
-
TC Erciyes UniversityEnrolling by invitationAromatherapy in Hemodialysis Patients with ItchingTurkey
-
Giresun UniversityCompleted
-
Selcuk UniversityEnrolling by invitationPrimiparous Mothers Who Gave Birth by Cesarean SectionTurkey
-
University of Applied Sciences of Western SwitzerlandSwiss National Science FoundationRecruitingChronic Kidney Disease Associated PruritusSwitzerland
-
TC Erciyes UniversityEnrolling by invitation